501 related articles for article (PubMed ID: 27058415)
1. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
[TBL] [Abstract][Full Text] [Related]
2. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.
Ji X; Tao R; Sun LY; Xu XL; Ling W
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3152-3165. PubMed ID: 32271433
[TBL] [Abstract][Full Text] [Related]
4. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
6. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
7. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
Xiong D; Jin C; Ye X; Qiu B; Jianjun X; Zhu S; Xiang L; Wu H; Yongbing W
Cancer Sci; 2018 Oct; 109(10):3080-3092. PubMed ID: 30098109
[TBL] [Abstract][Full Text] [Related]
8. Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
Wu D; Zhao B; Qi X; Peng F; Fu H; Chi X; Miao QR; Shao S
Cancer Lett; 2018 Apr; 418():135-146. PubMed ID: 29331415
[TBL] [Abstract][Full Text] [Related]
9. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
10. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
11. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
[TBL] [Abstract][Full Text] [Related]
12. Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.
Luo Q; Lin H; Ye X; Huang J; Lu S; Xu L
Int J Clin Oncol; 2015 Jun; 20(3):508-17. PubMed ID: 25345539
[TBL] [Abstract][Full Text] [Related]
13. Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition.
Meng Q; Xing Y; Ren T; Lu H; Xi Y; Jiang Z; Hu J; Li C; Sun L; Sun D; Cai L
Oncotarget; 2017 Apr; 8(14):22433-22442. PubMed ID: 27531895
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
[TBL] [Abstract][Full Text] [Related]
15. Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
Zhang X; Cai L; Zhou H; Liu Y; Fan C; Wang L; Li A; Miao Y; Li Q; Qiu X; Wang E
Mol Carcinog; 2017 Dec; 56(12):2558-2565. PubMed ID: 28667800
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic activation of SIN1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Hu Z; Wang Y; Wang Y; Zang B; Hui H; You Z; Wang X
Biochem Biophys Res Commun; 2017 Jan; 483(1):645-651. PubMed ID: 27993679
[TBL] [Abstract][Full Text] [Related]
17. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
Chen Y; Yang S; Zhou H; Su D
Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-105 promotes epithelial-mesenchymal transition of nonsmall lung cancer cells through upregulating Mcl-1.
Jin X; Yu Y; Zou Q; Wang M; Cui Y; Xie J; Wang Z
J Cell Biochem; 2019 Apr; 120(4):5880-5888. PubMed ID: 30317672
[TBL] [Abstract][Full Text] [Related]
19. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
20. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
Ye Z; Fang B; Pan J; Zhang N; Huang J; Xie C; Lou T; Cao Z
Oncol Rep; 2017 Jun; 37(6):3244-3252. PubMed ID: 28498463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]